Extended-release naltrexone plus medical management alcohol treatment in primary care: Findings at 15 months

Journal of Substance Abuse Treatment

Volumn 43, Issue 4, 2012, Pages 458-462

  Lee, Joshua D ^a   Grossman, Ellie ^a   Huben, Laura ^a   Manseau, Marc ^a   McNeely, Jennifer ^a   Rotrosen, John ^a   Stevens, David ^a,b   Gourevitch, Marc N ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK CITY HEALTH AND HOSPITALS CORPORATION   (United States)

Author keywords

Alcohol medical management; Alcohol pharmacotherapy; Alcohol treatment; Extended release naltrexone; Primary care

Indexed keywords

NALTREXONE;

ADULT; ALCOHOL ABSTINENCE; ALCOHOLICS ANONYMOUS; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG RELEASE; FEASIBILITY STUDY; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; TREATMENT DURATION;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; DELAYED-ACTION PREPARATIONS; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; PRIMARY HEALTH CARE; TEMPERANCE; TIME FACTORS;

EID: 84868142386     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2012.08.012     Document Type: Article

References (18)

1. Anton R.F., O'Malley S.S., Ciraulo D.A., Cisler R.A., Couper D., Donovan D.M., et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial. JAMA : The Journal of the American Medical Association 2006, 295:2003-2017.
2. Bryson W.C., McConnell J., Korthuis P.T., McCarty D. Extended-release naltrexone for alcohol dependence: Persistence and healthcare costs and utilization. American Journal of Managed Care 2011, 17(Suppl 8):S222-S234.
3. Buck J.A. The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act. Health Affairs 2011, 30(1):1402-1410.
4. Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration Alcohol Pharmacotherapies Into Medical Practice. Treatment Improvement Protocol (TIP) Series 49, HHS Publication No. SMA 09-4380 2009, (Rockville, MD).
5. Food and Drug Administration Meeting of the Psychopharmacologic Drugs Advisory Committee (accessed Dec. 10, 2011). http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/ucm225655.pdf.
6. Garbutt J.C. The state of pharmacotherapy for the treatment of alcohol dependence. Journal of Substance Abuse Treatment 2009, 36(1):S15-S23.
7. Garbutt J.C., Kranzler H.R., O'Malley S.S., Gastfriend D.R., Pettinati H.M., Silverman B.L., Loewy J.W., Ehrich E.W. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: A randomized controlled trial. JAMA : The Journal of the American Medical Association 2005, 293(13):1617-1625. Vivitrex Study Group.
8. Kim T.W., Saitz R., Cheng D.M., Winter M.R., Witas J., Samet J.H. Initiation and engagement in chronic disease management care for substance dependence. Drug and Alcohol Dependence 2011, 115(1-2):80-86.
9. Kranzler H.R., Stephenson J.J., Montejano L., Wang S., Gastfriend D.R. Persistence with oral naltrexone for alcohol treatment: Implications for health-care utilization. Addiction 2008, 103:1801-1808.
10. Krystal J.H., Cramer J.A., Krol W.F., Kirk G.F., Rosenheck R.A. Naltrexone in the treatment of alcohol dependence. NEJM 2001, 345:1734-1739.
11. Lee J.D., Delbanco B., Wu E., Gourevitch M.N. Substance use prevalence and screening instrument comparisons in urban primary care. Substance Abuse 2011, 32(3):128-134.
12. Lee J.D., Grossman E., DiRocco D., Gourevitch M.N. Home buprenorphine/naloxone induction in primary care. Journal of General Internal Medicine 2009, 24(2):226-232.
13. Lee J.D., Grossman E., DiRocco D., Truncali A., Hanley K., Stevens D., Rotrosen J., Gourevitch M.N. Extended-release naltrexone for treatment of alcohol dependence in primary care. Journal of Substance Abuse Treatment 2010, 39(1):14-21.
14. McLellan A.T., Lewis D.C., O'Brien C.P., Kleber H.D. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA : The Journal of the American Medical Association 2000, 284:1689-1695.
15. Mechanic D. Seizing opportunities under the Affordable Care Act for transforming the mental and behavioral health system. Health Affairs 2011, 31(2):376-382.
16. Saitz R., Larson M.J., Labelle C., Richardson J., Samet J.H. The case for chronic disease management for addiction. Journal of Addiction Medicine 2008, 2:55-65.
17. Substance Abuse and Mental Health Services Administration, National Survey on Drug Use and Health (retrieved Feb 15, 2012). http://www.samhsa.gov/data/NSDUH/2k10NSDUH/2k10Results.htm.
18. Substance Abuse and Mental Health Services Administration, Office of Applied Studies Treatment Episode Data Set (TEDS): 2005. Discharges from Substance Abuse Treatment Services. DHHS 2008, (Rockville, MD).